Clinical trial
Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or…
NCT00359632 · Pfizer, Industry · Terminated
Key facts
| NCT number | NCT00359632 |
|---|---|
| Title | Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or Greater |
| Official title | Prospective Study Of Ophthalmologic Function In Patients Receiving Linezolid For Six Weeks Or Greater |
| Lead sponsor | Pfizer, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Optic Nerve Diseases |
| Intervention type | Drug |
| Interventions | Zyvox - linezolid, Matched control |
| Enrollment | 34 |
| Start date | Nov 1, 2008 |
| Primary completion | Dec 1, 2013 |
| Completion | Dec 1, 2013 |
| First posted | Aug 2, 2006 |
| Last update posted | Jun 26, 2015 |
| Countries | Italy, Sweden, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: